Cited by 224Genetic Associations and EpidemiologyBlood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and Management

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Open access
Lindström, Sara, Wang, Lu, Smith, Erin N., Gordon, William, van Hylckama Vlieg, Astrid, de Andrade, Mariza, Brody, Jennifer A., Pattee, Jack W. +51 more·2019·Blood

Abstract

Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality. To advance our understanding of the biology contributing to VTE, we conducted a genome-wide association study (GWAS) of VTE and a transcriptome-wide association study (TWAS) based on imputed gene expression from whole blood and liver. We meta-analyzed GWAS data from 18 studies for 30 234 VTE cases and 172 122 controls and assessed the association between 12 923 718 genetic variants and VTE. We generated variant prediction scores of gene expression from whole blood and liver tissue and assessed them for association with VTE. Mendelian randomization analyses were conducted for traits genetically associated with novel VTE loci. We identified 34 independent genetic signals for VTE risk from GWAS meta-analysis, of which 14 are newly reported associations. This included 11 newly associated genetic loci (C1orf198, PLEK, OSMR-AS1, NUGGC/SCARA5, GRK5, MPHOSPH9, ARID4A, PLCG2, SMG6, EIF5A, and STX10) of which 6 replicated, and 3 new independent signals in 3 known genes. Further, TWAS identified 5 additional genetic loci with imputed gene expression levels differing between cases and controls in whole blood (SH2B3, SPSB1, RP11-747H7.3, RP4-737E23.2) and in liver (ERAP1). At some GWAS loci, we found suggestive evidence that the VTE association signal for novel and previously known regions colocalized with expression quantitative trait locus signals. Mendelian randomization analyses suggested that blood traits may contribute to the underlying risk of VTE. To conclude, we identified 16 novel susceptibility loci for VTE; for some loci, the association signals are likely mediated through gene expression of nearby genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2019000435

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Common genetic variants in PLCG2 link the enzyme to type 1 diabetes and venous thromboembolism.

    “Common genetic variants in PLCG2 also link the enzyme to type 1 diabetes (119) and venous thromboembolism (120), which could have a shared autoimmune etiology.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Egeberg O. Thrombophilia caused by inheritable deficiency of blood anti- thrombin. Scand J Clin Lab Invest. 1965; 17(1):92.
  2. Klarin D, Busenkell E, Judy R, et al. Genetic analysis of venous thromboembolism high- lights the genetic overlap of thrombosis with lipids and arterial vascular disease. Nat Genet. In press.
  3. Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as medi- ators of immunity, inflammation, and throm- bosis. Circ Res. 2018;122(2):337-351.

Cited by

Sorted by citations

Authors
Lindström, S., Wang, L., Smith, E. N., Gordon, W., van Hylckama Vlieg, A., de Andrade, M., Brody, J. A., Pattee, J. W., Haessler, J., Brumpton, B. M., Chasman, D. I., Suchon, P., Chen, M.-H., Turman, C., Germain, M., Wiggins, K. L., MacDonald, J., Braekkan, S. K., Armasu, S. M., Pankratz, N., Jackson, R. D., Nielsen, J. B., Giulianini, F., Puurunen, M. K., Ibrahim, M., Heckbert, S. R., Damrauer, S. M., Natarajan, P., Klarin, D., Program, T. M. V., de Vries, P. S., Sabater-Lleal, M., Huffman, J. E., The CHARGE Hemostasis Working Group, Bammler, T. K., Frazer, K. A., McCauley, B. M., Taylor, K., Pankow, J. S., Reiner, A. P., Gabrielsen, M. E., Deleuze, J.-F., O'Donnell, C. J., Kim, J., McKnight, B., Kraft, P., Hansen, J.-B., Rosendaal, F. R., Heit, J. A., Psaty, B. M., Tang, W., Kooperberg, C., Hveem, K., Ridker, P. M., Morange, P.-E., Johnson, A. D., Kabrhel, C., Trégouët, D.-A., & Smith, N. L.
Affiliations
  • University of Washington (US)
  • University of California San Diego (US)
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands;
  • Department of Health Sciences Research, Mayo Clinic, Rochester, MN;
  • University of Minnesota (US)
  • Fred Hutch Cancer Center (US)
  • Norwegian University of Science and Technology (NO)
  • Brigham and Women's Hospital (US)
  • Inserm (FR)
  • National Institutes of Health (US)
  • Harvard University (US)
  • Université de Bordeaux (FR)
  • K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT–The Arctic University of Norway, Tromsø, Norway;
  • Mayo Clinic (US)
  • The Ohio State University (US)
  • University of Michigan (US)
  • Framingham Heart Study (US)
  • Hôpital de la Timone (FR)
  • Kaiser Permanente Washington Health Research Institute (US)
  • Philadelphia VA Medical Center (US)
  • Broad Institute (US)
  • The University of Texas Health Science Center at Houston (US)
  • Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX;
  • Unit of Genomics of Complex Diseases, Institut de Recerca de l’Hospital de Sant Pau, IIB-Sant Pau, Barcelona, Spain;
  • University of California, Los Angeles (US)
  • Department of Epidemiology, University of Washington, Seattle, WA;
  • University Hospital of North Norway (NO)
  • United States Department of Veterans Affairs (US)
Venue
Blood
Published
2019-08-16
Volume
134
Issue
19
Pages
1645-1657
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2968081931
Cited by
223
References
98
Citations by year
2026: 15 · 2025: 31 · 2024: 34 · 2023: 45 · 2022: 38 · 2021: 38 · 2020: 18 · 2019: 4
FWCI
14.77
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HAL (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
Funders
  • U.S. Department of Health and Human Services
  • Stiftelsen Kristian Gerhard Jebsen
  • Agence Nationale de la Recherche (ANR-10-LABX-0013)
  • National Institutes of Health (1r01hl120393-01a1, HL141791)
  • National Heart, Lung, and Blood Institute (HL134894, R61HL141791, HL116854, R01-HL120393, R01HL134894, U01HL130114, HL141791, U01HL120393, HL139553, R01HL116854, R01HL059367, R01HL105756, R33HL141791, R01HL139553)
  • National Cancer Institute (U01CA182913)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords
venous thromboembolism, genetic susceptibility loci, transcriptome-wide association study, whole blood gene expression, hepatic gene expression, expression quantitative trait loci, Mendelian randomization, blood characteristics, pleckstrin, GRK5, PLCγ2, SMG6, eIF5A, SH2B3, ERAP1, thrombosis risk
MeSH terms
Humans, Genetic Predisposition to Disease, Venous Thromboembolism, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review